Aferdita Spahillari is a Cardiology physician. OpenAlex indexes 53 publications with 541 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
330 Brookline Ave
Boston, MA 022155400
Telephone
617-667-8800Registry record last updated 24 May 2016.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
79%Aldosterone antagonist (MRA)19.6%Spironolactone100%Part D≥40 patientsAngiotensin receptor-neprilysin inhibitor (ARNI)18.3%Entresto100%Part D≥34 patients+ 4 more classes in this area
Metabolism & gastrointestinal
17.6%SGLT2 inhibitor15%Jardiance72%Farxiga28%Part D<11 patientsPotassium supplement2.6%Potassium Chloride100%Part D<11 patientsBlood & clotting
3.4%Factor Xa inhibitor3.4%Eliquis100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 26-A-14911-ACC IMPLEMENTATION AND OUTCOMES OF GLP-1 RECEPTOR AGONIST TITRATION (GLP-1RA) IN A HEART FAILURE CLINIC
Journal of the American College of Cardiology
2026 - Contemporary Management of Acute Heart Failure: From Emergency Presentation to Long-Term Remission.
Open Access CRIS of the University of Bern
2026 - Single Ascending-Dose Study of Selective ErbB4 Agonist JK07 in Heart Failure With Reduced Ejection Fraction
JACC Basic to Translational Science
2025
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”